These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16460608)

  • 1. Vinorelbine and venous irritation: optimal parenteral administration.
    de Lemos ML
    J Oncol Pharm Pract; 2005 Jun; 11(2):79-81. PubMed ID: 16460608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity.
    Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Kakinuma R; Saijo N; Nishiwaki Y
    Lung Cancer; 2007 Mar; 55(3):337-41. PubMed ID: 17126951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phlebitis after vinorelbine].
    Sauter C; Margulies A; Pestalozzi B
    Schweiz Med Wochenschr; 1998 Feb; 128(9):343. PubMed ID: 9544462
    [No Abstract]   [Full Text] [Related]  

  • 4. [The incidence of phlebitis in the patients administrated vinorelbine by intravenous bolus injection--a retrospective study].
    Nakayama S; Matsubara N; Sakai T; Aso N
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):633-5. PubMed ID: 11977554
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prophylaxis of toxic effects on the peripheral venous system associated with intravenous administration of vinorelbine].
    Cinieri S; Orlando L; Cocorocchio E; Munzone E; Catania C; Brunetti C; Rocca A; Martinelli G; Nolè F
    Clin Ter; 1999; 150(3):225-9. PubMed ID: 10528436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing and managing venous irritation associated with vinorelbine tartrate (Navelbine).
    Rittenberg CN; Gralla RJ; Rehmeyer TA
    Oncol Nurs Forum; 1995 May; 22(4):707-10. PubMed ID: 7675673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits.
    Kohno E; Murase S; Nishikata M; Okamura N; Matzno S; Kuwahara T; Matsuyama K
    Int J Med Sci; 2008 Jul; 5(4):218-23. PubMed ID: 18695742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High body mass index correlates with increased risk of venous irritation by vinorelbine infusion.
    Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Kakinuma R; Nishiwaki Y
    Jpn J Clin Oncol; 2004 Apr; 34(4):206-9. PubMed ID: 15121757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in the vinorelbine-induced venous irritation by pharmaceutical intervention.
    Yamada T; Egashira N; Watanabe H; Nagata K; Yano T; Nonaka T; Oishi R
    Support Care Cancer; 2012 Jul; 20(7):1549-53. PubMed ID: 21805382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of vinorelbine phlebitis with cimetidine. A two-step design study.
    Vassilomanolakis M; Koumakis G; Barbounis V; Orphanos G; Efremidis A
    Support Care Cancer; 2001 Mar; 9(2):108-11. PubMed ID: 11305068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Consideration of preventive free-flowing IV infusion method for vinorelbine].
    Suga Y; Hara Y; Hashimoto H; Nishigami J; Shimizu M; Akasaka H; Hayashi K; Yonejima M; Nakamura M; Inokuchi M; Kasahara K; Nishimura G; Miyamoto K
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1255-7. PubMed ID: 17687207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic treatment of local reactions to i.v. vinorelbine: a randomized study.
    Quant E; Bergman B
    Support Care Cancer; 2012 Aug; 20(8):1737-44. PubMed ID: 21922202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral versus intravenous administration of vinorelbine as a single agent for the first-line treatment of metastatic nonsmall cell lung carcinoma (NSCLC): A randomized phase II trial.
    Hirsh V; Desjardins P; Needles BM; Rigas JR; Jahanzeb M; Nguyen L; Zembryki D; Leopold LH
    Am J Clin Oncol; 2007 Jun; 30(3):245-51. PubMed ID: 17551300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinflunine.
    Shnyder SD
    IDrugs; 2004 Sep; 7(9):851-9. PubMed ID: 15470603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate.
    Mackler NJ; Dunn RL; Hellerstedt B; Cooney KA; Fardig J; Olson K; Pienta KJ; Smith DC
    Cancer; 2006 Jun; 106(12):2617-23. PubMed ID: 16691618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the editor.
    Wilmott V; Humphries M; Grozdanov S
    J Oncol Pharm Pract; 2006 Jun; 12(2):123. PubMed ID: 16984752
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of corticosteroids on phlebitis induced by intravenous infusion of antineoplastic agents in rabbits.
    Kohno E; Murase S; Matsuyama K; Okamura N
    Int J Med Sci; 2009 Aug; 6(5):218-23. PubMed ID: 19680474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin necrosis from extravasation of vinorelbine.
    Moreno de Vega MJ; Dauden E; Abajo P; Bartolome B; Fraga J; Garcia-Diez A
    J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):488-90. PubMed ID: 12428844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral vinorelbine may not induce acute pain at the tumor site.
    Tralongo P; Di Mari A; Agueli R; Gebbia V
    J Pain Symptom Manage; 2006 Sep; 32(3):197-9. PubMed ID: 16939839
    [No Abstract]   [Full Text] [Related]  

  • 20. Concurrent administration of vinorelbine with recombinant human granulocyte colony-stimulating factor: an effective method of increasing dose intensity.
    Weiss AJ; Sabol J; Lackman RD
    Am J Clin Oncol; 1999 Feb; 22(1):38-41. PubMed ID: 10025378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.